Baudax Bio, Inc. (BXRXQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Oct 25, 2024, 8:30 AM EST
Baudax Bio Market Cap
Baudax Bio has a market cap or net worth of $52.00 as of December 27, 2024. Its market cap has decreased by -100.00% in one year.
Market Cap
52.00
Enterprise Value
16.77M
Revenue
1.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since November 18, 2019, Baudax Bio's market cap has decreased from 54.92M to 52.00, a decrease of -100.00%. That is a compound annual growth rate of -93.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2024 | 52.00 | -100.00% |
| Dec 29, 2023 | 1.15M | -34.59% |
| Dec 30, 2022 | 1.76M | -90.48% |
| Dec 31, 2021 | 18.54M | -30.04% |
| Dec 31, 2020 | 26.50M | -59.05% |
| Dec 31, 2019 | 64.71M | 17.82% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sandoz Group AG | 18.07B |
| Telix Pharmaceuticals Limited | 5.22B |
| Elekta AB (publ) | 2.09B |
| Ryman Healthcare Limited | 1.72B |
| Verano Holdings Corp. | 463.76M |
| Vireo Growth Inc. | 129.65M |
| Medexus Pharmaceuticals Inc. | 55.68M |